Helen Stephenson-Ellis
Corporate Officer/Principal bei Chartered Institute of Personnel & Development
Profil
Helen Stephenson-Ellis is a professional with experience in human resources.
She is currently a member of the Chartered Institute of Personnel & Development.
Previously, she worked as a Director of Human Resources at AstraZeneca PLC and Ligand UK Ltd.
She also served as the Chief People Officer at Oxford Biomedica Plc from 2018 to 2022.
Additionally, she was the Head of Human Resources at Medimmune UK Ltd.
Ms. Stephenson-Ellis obtained an undergraduate degree from the University of Northumbria.
Aktive Positionen von Helen Stephenson-Ellis
| Unternehmen | Position | Beginn |
|---|---|---|
| Chartered Institute of Personnel & Development | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Helen Stephenson-Ellis
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD BIOMEDICA PLC | Human Resources Officer | 01.05.2022 |
| VERNALIS | Human Resources Officer | - |
Medimmune UK Ltd.
 Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Human Resources Officer | - |
| ASTRAZENECA PLC | Human Resources Officer | - |
Ausbildung von Helen Stephenson-Ellis
| University of Northumbria | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Medimmune UK Ltd.
Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Process Industries |
